TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive Cancer Prevention: NSABP Publishes P-1 Data, Finds Risk Of Breast Cancer Cut By 49 Percent September 18, 1998
TCL Archive Organ Systems Program Progress, Momentum Threatened During transition, Karr Contends December 9, 1988